NAGE

MKT CAP:$288M

Niagen Bioscience, Inc.

Market Cap

$288M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$3.45-$2.80 (-44.80%)

Jun 5, 2026

52W High $14.4152W Low $3.44

Company Details

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement product...

CEO

—

IPO Date

Jul 15, 2008

Website

www.niagenbioscience.com

Key Metrics TTM

Revenue

$130M

+20.8% YoY

Net Income

$19M

EPS (Diluted)

Free Cash Flow

$4M

Revenue / Share

$1.54

Gross Margin

64.3%

Operating Margin

8.5%

Net Margin

14.3%

FCF Margin

3.1%

P/S

2.2x

P/E

15.4x

Earnings Reports

Q2 2026

Aug 5, 2026

PENDING

Q1 2026

May 6, 2026

$31M+3.3%

FY 2025

Mar 11, 2026

$129M+29.9%

Q4 2025

Mar 11, 2026

$34M+16.2%

Q3 2025

Nov 4, 2025

$34M+32.9%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee